Radiopharm Theranostics Limited (RADX)
NASDAQ: RADX · Real-Time Price · USD
4.230
-0.162 (-3.69%)
At close: Dec 9, 2025, 4:00 PM EST
4.690
+0.460 (10.87%)
After-hours: Dec 9, 2025, 6:53 PM EST
Radiopharm Theranostics Market Cap
Radiopharm Theranostics has a market cap or net worth of $35.31 million as of December 9, 2025. Its market cap has decreased by -3.76% in one year.
Market Cap
35.31M
Enterprise Value
14.66M
1-Year Change
-3.76%
Ranking
Category
Stock Price
$4.23
Market Cap Chart
Since November 25, 2021, Radiopharm Theranostics's market cap has decreased from $72.85M to $35.31M, a decrease of -51.54%. That is a compound annual growth rate of -16.41%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 9, 2025 | 35.13M | 7.84% |
| Dec 31, 2024 | 32.58M | 73.79% |
| Dec 29, 2023 | 18.75M | -20.04% |
| Dec 30, 2022 | 23.45M | -67.78% |
| Dec 31, 2021 | 72.76M | -0.12% |
| Nov 25, 2021 | 72.85M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 893.23B |
| Johnson & Johnson | 485.76B |
| AbbVie | 394.34B |
| UnitedHealth Group | 293.15B |
| AstraZeneca | 280.30B |
| Novartis AG | 253.21B |
| Merck & Co. | 245.55B |
| Thermo Fisher Scientific | 213.48B |